Viewing Study NCT01889420

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 4:19 AM
Ignite Modification Date: 2026-01-16 @ 1:33 AM
Study NCT ID: NCT01889420
Status: TERMINATED
Last Update Posted: 2015-07-31
First Post: 2013-06-26
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Phase I Trial of Everolimus, Pomalidomide and Dexamethasone in Patients With Relapsed/Refractory Multiple Myeloma
Sponsor: New Mexico Cancer Research Alliance
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Multiple Myeloma in Relapse View
Keywords:

Keywords

Keyword Brief Keyword Text View
None myeloma View
None relapse View
None refractory View
None relapsed View
None pomalidomide View
None pomalyst View
None everolimus View
None afinitor View
None dexamethasone View